Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Testing light therapy and sleep changes for fibromyalgia symptoms

Official title: At Home Morning Bright Light Treatment for Chronic Nociplastic Pain

Run by University of Michigan · NCT06567886 · Data updated 2026-11-12

This study is testing if using a special light in the morning and changing sleep habits can help people with fibromyalgia feel better.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment390 (estimated)
SponsorUniversity of Michigan
Academic / other
Locations1 site (Ann Arbor, Michigan)
StatusRecruiting
StartedSeptember 27, 2024
Main results expectedMarch 2029
Study endsMarch 2029
Registry record updatedJune 4, 2026
Trial IDNCT06567886 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with fibromyalgia who have access to video conferencing technology.

Probably not a fit

Patients with significant chronic diseases or severe cognitive impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of sleep timing stabilization and morning light therapy on symptoms of fibromyalgia. Participants will use a consumer health light therapy device called Re-Timer to assess its impact on their condition. The study will be conducted remotely, allowing participants to engage via video conferencing. The goal is to determine if these interventions can improve the quality of life for individuals suffering from fibromyalgia.

Why it matters

Potential benefit: If successful, this study could provide a non-invasive treatment option to alleviate fibromyalgia symptoms.

How similar studies have gone: Other studies have shown promising results with light therapy for various conditions, suggesting potential for success in this novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Meets 2016 revised diagnostic criteria for fibromyalgia (FM)
2. Has access to video conferencing (including web cameras and audio) and a private space for the remote study visits.

Exclusion Criteria:

1. Significant chronic disease
2. Severe hearing or memory problems
3. Pending medical leave applications at workplace
4. Current pregnancy, breastfeeding, or actively trying to get pregnant
5. Night work or travel outside the eastern time zone within 1 month of the study
6. Other research participation
7. Frequent number of special events during study period (weddings, concerts, exams, etc).

Where it's running

  • University of Michigan
    Ann Arbor, Michigan, United States
    Recruiting

Study contacts

  • Principal investigator: Afton Hassett — University of Michigan
  • Study coordinator: Helen Burgess
  • Email: bhelen@umich.edu
  • Phone: 734-615-8303

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.